These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34069242)

  • 1. COVID-19 Vaccination in Developing Nations: Challenges and Opportunities for Innovation.
    Sheikh AB; Pal S; Javed N; Shekhar R
    Infect Dis Rep; 2021 May; 13(2):429-436. PubMed ID: 34069242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVAX and equitable access to COVID-19 vaccines.
    Yoo KJ; Mehta A; Mak J; Bishai D; Chansa C; Patenaude B
    Bull World Health Organ; 2022 May; 100(5):315-328. PubMed ID: 35521037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prioritizing 'equity' in COVID-19 vaccine distribution through Global Health Diplomacy.
    Singh B; Chattu VK
    Health Promot Perspect; 2021; 11(3):281-287. PubMed ID: 34660222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.
    Kazemi M; Bragazzi NL; Kong JD
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Pandemic and Equal Access to Vaccines.
    Bolcato M; Rodriguez D; Feola A; Di Mizio G; Bonsignore A; Ciliberti R; Tettamanti C; Trabucco Aurilio M; Aprile A
    Vaccines (Basel); 2021 May; 9(6):. PubMed ID: 34063863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVAX, vaccine donations and the politics of global vaccine inequity.
    de Bengy Puyvallée A; Storeng KT
    Global Health; 2022 Mar; 18(1):26. PubMed ID: 35248116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination strategies in developing countries.
    Poore P
    Vaccine; 1988 Oct; 6(5):393-8. PubMed ID: 3057759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reserving coronavirus disease 2019 vaccines for global access: cross sectional analysis.
    So AD; Woo J
    BMJ; 2020 Dec; 371():m4750. PubMed ID: 33323376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expert Views on COVAX and Equitable Global Access to COVID-19 Vaccines.
    Manriquez Roa T; Holzer F; Luna F; Biller-Andorno N
    Int J Public Health; 2021; 66():1604236. PubMed ID: 35035347
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 Vaccines: How Efficient and Equitable Was the Initial Vaccination Process?
    Das JK; Chee HY; Lakhani S; Khan MH; Islam M; Muhammad S; Bhutta ZA
    Vaccines (Basel); 2022 Dec; 11(1):. PubMed ID: 36679856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uneven power dynamics must be levelled in COVID-19 vaccines access and distribution.
    Alaran AJ; Adebisi YA; Badmos A; Khalid-Salako F; Gaya SK; Ilesanmi EB; Olaoye DQ; Bamisaiye A; Lucero-Prisno DE
    Public Health Pract (Oxf); 2021 Nov; 2():100096. PubMed ID: 33615282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical programming approach for equitable COVID-19 vaccine distribution in developing countries.
    Tavana M; Govindan K; Nasr AK; Heidary MS; Mina H
    Ann Oper Res; 2021 Jun; ():1-34. PubMed ID: 34099948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
    Gorodensky A; Kohler JC
    J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.
    Shen AK; Hughes Iv R; DeWald E; Rosenbaum S; Pisani A; Orenstein W
    Health Aff (Millwood); 2021 Jan; 40(1):62-69. PubMed ID: 33211542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. People's Willingness to Vaccinate Against COVID-19 Despite Their Safety Concerns: Twitter Poll Analysis.
    Eibensteiner F; Ritschl V; Nawaz FA; Fazel SS; Tsagkaris C; Kulnik ST; Crutzen R; Klager E; Völkl-Kernstock S; Schaden E; Kletecka-Pulker M; Willschke H; Atanasov AG
    J Med Internet Res; 2021 Apr; 23(4):e28973. PubMed ID: 33872185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999-2014).
    Gandhi G
    BMC Public Health; 2015 Nov; 15():1198. PubMed ID: 26621528
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.